{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:42:32Z","timestamp":1791333752281,"version":"4.3.1"},"reference-count":61,"publisher":"Rockefeller University Press","issue":"10","license":[{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.rupress.org\/terms\/"},{"start":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T00:00:00Z","timestamp":1617580800000},"content-version":"vor","delay-in-days":285,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Milieu Int\u00e9rieur","award":["ANR-10-LABX-69-01"],"award-info":[{"award-number":["ANR-10-LABX-69-01"]}]},{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Institut Roche"},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-2013-StG 337146"],"award-info":[{"award-number":["ERC-2013-StG 337146"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["2016-16365"],"award-info":[{"award-number":["2016-16365"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["2019-19241"],"award-info":[{"award-number":["2019-19241"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10,5]]},"abstract":"<jats:p>Rare individuals can naturally clear chronic hepatitis B virus (HBV) infection and acquire protection from reinfection as conferred by vaccination. To examine the protective humoral response against HBV, we cloned and characterized human antibodies specific to the viral surface glycoproteins (HBsAg) from memory B cells of HBV vaccinees and controllers. We found that human HBV antibodies are encoded by a diverse set of immunoglobulin genes and recognize various conformational HBsAg epitopes. Strikingly, HBsAg-specific memory B cells from natural controllers mainly produced neutralizing antibodies able to cross-react with several viral genotypes. Furthermore, monotherapy with the potent broadly neutralizing antibody Bc1.187 suppressed viremia in vivo in HBV mouse models and led to post-therapy control of the infection in a fraction of animals. Thus, human neutralizing HBsAg antibodies appear to play a key role in the spontaneous control of HBV and represent promising immunotherapeutic tools for achieving HBV functional cure in chronically infected humans.<\/jats:p>","DOI":"10.1084\/jem.20200840","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T02:21:56Z","timestamp":1591323716000},"update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":58,"title":["Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers"],"prefix":"10.1084","volume":"217","author":[{"given":"Verena","family":"Hehle","sequence":"first","affiliation":[{"name":"Laboratory of Humoral Immunology, Department of Immunology, Institut Pasteur, Paris, France 1"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1222, Paris, France 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6202-1948","authenticated-orcid":true,"given":"Maxime","family":"Beretta","sequence":"additional","affiliation":[{"name":"Laboratory of Humoral Immunology, Department of Immunology, Institut Pasteur, Paris, France 1"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1222, Paris, France 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8850-8073","authenticated-orcid":true,"given":"Maryline","family":"Bourgine","sequence":"additional","affiliation":[{"name":"Molecular Virology and Vaccinology Unit, Institut Pasteur, Paris, France 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malika","family":"Ait-Goughoulte","sequence":"additional","affiliation":[{"name":"Roche Innovation Center, Basel, Switzerland 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5142-7253","authenticated-orcid":true,"given":"Cyril","family":"Planchais","sequence":"additional","affiliation":[{"name":"Laboratory of Humoral Immunology, Department of Immunology, Institut Pasteur, Paris, France 1"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1222, Paris, France 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solen","family":"Morisse","sequence":"additional","affiliation":[{"name":"Molecular Virology and Vaccinology Unit, Institut Pasteur, Paris, France 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Vesin","sequence":"additional","affiliation":[{"name":"Molecular Virology and Vaccinology Unit, Institut Pasteur, Paris, France 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Lorin","sequence":"additional","affiliation":[{"name":"Laboratory of Humoral Immunology, Department of Immunology, Institut Pasteur, Paris, France 1"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1222, Paris, France 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Hieu","sequence":"additional","affiliation":[{"name":"Laboratory of Humoral Immunology, Department of Immunology, Institut Pasteur, Paris, France 1"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1222, Paris, France 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7141-2104","authenticated-orcid":true,"given":"Andrea","family":"Stauffer","sequence":"additional","affiliation":[{"name":"Roche Innovation Center, Basel, Switzerland 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriane","family":"Fiquet","sequence":"additional","affiliation":[{"name":"Innate Immunity Unit, Department of Immunology, Paris, France 5"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1223, Institut Pasteur, Paris, France 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan D.","family":"Dimitrov","sequence":"additional","affiliation":[{"name":"Centre de Recherche des Cordeliers, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Sorbonne Universit\u00e9, Universit\u00e9 de Paris, Paris, France 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1231-845X","authenticated-orcid":true,"given":"Marie-Louise","family":"Michel","sequence":"additional","affiliation":[{"name":"Institut Pasteur, Paris, France 8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-No\u00eblle","family":"Ungeheuer","sequence":"additional","affiliation":[{"name":"Investigation Clinique et Acc\u00e8s aux Ressources Biologiques platform, Center for Translational Science, Institut Pasteur, Paris, France 9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0517-4646","authenticated-orcid":true,"given":"Camille","family":"Sureau","sequence":"additional","affiliation":[{"name":"Institut National de la Transfusion Sanguine, Centre National de la Recherche\u2013Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1134, Paris, France 10"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas","family":"Pol","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1223, Institut Pasteur, Paris, France 6"},{"name":"Hepatology Department, Cochin Hospital, Assistance publique \u2013 H\u00f4pitaux de Paris, Paris, France 11"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7146-1862","authenticated-orcid":true,"given":"James P.","family":"Di Santo","sequence":"additional","affiliation":[{"name":"Innate Immunity Unit, Department of Immunology, Paris, France 5"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1223, Institut Pasteur, Paris, France 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Strick-Marchand","sequence":"additional","affiliation":[{"name":"Innate Immunity Unit, Department of Immunology, Paris, France 5"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1223, Institut Pasteur, Paris, France 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7097-6760","authenticated-orcid":true,"given":"Nad\u00e8ge","family":"Pelletier","sequence":"additional","affiliation":[{"name":"Roche Innovation Center, Basel, Switzerland 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4230-610X","authenticated-orcid":true,"given":"Hugo","family":"Mouquet","sequence":"additional","affiliation":[{"name":"Laboratory of Humoral Immunology, Department of Immunology, Institut Pasteur, Paris, France 1"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1222, Paris, France 2"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2020,6,24]]},"reference":[{"key":"2023072812282831000_bib1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad0522","article-title":"Immune history profoundly affects broadly protective B cell responses to influenza","volume":"7","author":"Andrews","year":"2015","journal-title":"Sci. Transl. Med"},{"key":"2023072812282831000_bib2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1159\/000329809","article-title":"Immune control of hepatitis B virus","volume":"29","author":"Bauer","year":"2011","journal-title":"Dig. Dis"},{"key":"2023072812282831000_bib3","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1136\/gutjnl-2011-301073","article-title":"Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection","volume":"61","author":"Bertoletti","year":"2012","journal-title":"Gut"},{"issue":"1","key":"2023072812282831000_bib4","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.jhep.2016.01.026","article-title":"Adaptive immunity in HBV infection","volume":"64","author":"Bertoletti","year":"2016","journal-title":"J. Hepatol"},{"key":"2023072812282831000_bib5","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1172\/JCI121960","article-title":"Circulating and intrahepatic antiviral B cells are defective in hepatitis B","volume":"128","author":"Burton","year":"2018","journal-title":"J. Clin. Invest"},{"key":"2023072812282831000_bib6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.coviro.2019.02.004","article-title":"VH1-69 antiviral broadly neutralizing antibodies: genetics, structures, and relevance to rational vaccine design","volume":"34","author":"Chen","year":"2019","journal-title":"Curr. Opin. Virol"},{"key":"2023072812282831000_bib7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrgastro.2009.107","article-title":"Hepatitis B virus variants","volume":"6","author":"Chotiyaputta","year":"2009","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"key":"2023072812282831000_bib8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/978-3-319-22330-8_11","volume-title":"Hepatitis B Virus in Human Diseases","author":"Chu","year":"2016"},{"key":"2023072812282831000_bib9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.coviro.2018.04.002","article-title":"Viral envelope-specific antibodies in chronic hepatitis B virus infection","volume":"30","author":"Corti","year":"2018","journal-title":"Curr. Opin. Virol"},{"key":"2023072812282831000_bib10","doi-asserted-by":"publisher","first-page":"ra1","DOI":"10.1126\/scisignal.2001906","article-title":"Inhibition of PP1 phosphatase activity by HBx: a mechanism for the activation of hepatitis B virus transcription","volume":"5","author":"Cougot","year":"2012","journal-title":"Sci. Signal"},{"key":"2023072812282831000_bib11","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1128\/JVI.03134-12","article-title":"Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules","volume":"87","author":"Dion","year":"2013","journal-title":"J. Virol"},{"key":"2023072812282831000_bib12","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1053\/j.gastro.2017.08.034","article-title":"Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver","volume":"153","author":"Duss\u00e9aux","year":"2017","journal-title":"Gastroenterology"},{"key":"2023072812282831000_bib13","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1053\/jhep.2000.9632","article-title":"Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees","volume":"32","author":"Eren","year":"2000","journal-title":"Hepatology"},{"key":"2023072812282831000_bib14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic strategies for hepatitis B virus infection: towards a cure","volume":"18","author":"Fanning","year":"2019","journal-title":"Nat. Rev. Drug Discov"},{"key":"2023072812282831000_bib15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1053\/jhep.2002.31867","article-title":"Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties","volume":"35","author":"Galun","year":"2002","journal-title":"Hepatology"},{"key":"2023072812282831000_bib16","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1080\/21645515.2017.1319021","article-title":"Antibody-mediated immunotherapy against chronic hepatitis B virus infection","volume":"13","author":"Gao","year":"2017","journal-title":"Hum. Vaccin. Immunother"},{"key":"2023072812282831000_bib17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1053\/j.gastro.2018.10.032","article-title":"Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection","volume":"156","author":"Gehring","year":"2019","journal-title":"Gastroenterology"},{"key":"2023072812282831000_bib18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1099\/vir.0.004861-0","article-title":"Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells","volume":"90","author":"Hantz","year":"2009","journal-title":"J. Gen. Virol"},{"issue":"Database issue","key":"2023072812282831000_bib19","doi-asserted-by":"publisher","first-page":"D566","DOI":"10.1093\/nar\/gks1022","article-title":"HBVdb: a knowledge database for Hepatitis B Virus","volume":"41","author":"Hayer","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2023072812282831000_bib20","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jhep.2012.05.009","article-title":"Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors","volume":"57","author":"Huang","year":"2012","journal-title":"J. Hepatol"},{"key":"2023072812282831000_bib21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-3-319-22330-8_3","volume-title":"Hepatitis B Virus in Human Diseases","author":"Kato","year":"2016"},{"key":"2023072812282831000_bib22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.virusres.2015.10.024","article-title":"New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen","volume":"211","author":"Kucinskaite-Kodze","year":"2016","journal-title":"Virus Res"},{"key":"2023072812282831000_bib23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1182\/blood-2018-04-848044","article-title":"Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy","volume":"133","author":"Kusumoto","year":"2019","journal-title":"Blood"},{"key":"2023072812282831000_bib24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0161-5890(99)00074-7","article-title":"Characterization of neutralizing anti-pre-S1 and anti-pre-S2 (HBV) monoclonal antibodies and their fragments","volume":"36","author":"K\u00fcttner","year":"1999","journal-title":"Mol. Immunol"},{"key":"2023072812282831000_bib25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.09.038","article-title":"Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus Infection","author":"Lee","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol"},{"key":"2023072812282831000_bib26","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/0140-6736(90)93069-2","article-title":"Monoclonal antibody to HBsAg for chronic hepatitis B virus infection with hypogammaglobulinaemia","volume":"335","author":"Lever","year":"1990","journal-title":"Lancet"},{"key":"2023072812282831000_bib27","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.26738","article-title":"A potent human neutralizing antibody Fc-dependently reduces established HBV infections","volume":"6","author":"Li","year":"2017","journal-title":"eLife"},{"key":"2023072812282831000_bib28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jim.2015.04.010","article-title":"Efficient generation of human IgA monoclonal antibodies","volume":"422","author":"Lorin","year":"2015","journal-title":"J. Immunol. Methods"},{"key":"2023072812282831000_bib29","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41575-019-0196-9","article-title":"Restoring, releasing or replacing adaptive immunity in chronic hepatitis B","volume":"16","author":"Maini","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"issue":"5","key":"2023072812282831000_bib30","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1002\/hep.22898","article-title":"The natural history of chronic hepatitis B virus infection","volume":"49","author":"McMahon","year":"2009","journal-title":"Hepatology"},{"key":"2023072812282831000_bib31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1084\/jem.20031550","article-title":"Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies","volume":"199","author":"Meffre","year":"2004","journal-title":"J. Exp. Med"},{"key":"2023072812282831000_bib32","doi-asserted-by":"publisher","first-page":"7708","DOI":"10.1073\/pnas.81.24.7708","article-title":"Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin","volume":"81","author":"Michel","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023072812282831000_bib33","doi-asserted-by":"publisher","first-page":"6517","DOI":"10.4049\/jimmunol.177.9.6517","article-title":"A truncated alternative spliced isoform of human desmoglein 1 contains a specific T cell epitope binding to the pemphigus foliaceus-associated HLA class II DRbeta1*0102 molecule","volume":"177","author":"Mouquet","year":"2006","journal-title":"J. Immunol"},{"key":"2023072812282831000_bib34","doi-asserted-by":"publisher","first-page":"E3268","DOI":"10.1073\/pnas.1217207109","article-title":"Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies","volume":"109","author":"Mouquet","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023072812282831000_bib35","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tim.2015.07.005","article-title":"Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents?","volume":"23","author":"Pelegrin","year":"2015","journal-title":"Trends Microbiol"},{"key":"2023072812282831000_bib36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/j.gastro.2014.10.038","article-title":"American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy","volume":"148","author":"Perrillo","year":"2015","journal-title":"Gastroenterology"},{"key":"2023072812282831000_bib37","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.celrep.2019.03.032","article-title":"HIV-1 Envelope Recognition by Polyreactive and Cross-Reactive Intestinal B Cells","volume":"27","author":"Planchais","year":"2019","journal-title":"Cell Rep"},{"key":"2023072812282831000_bib38","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1002\/eji.201646446","article-title":"Scarcity of autoreactive human blood IgA+ memory B cells","volume":"46","author":"Prigent","year":"2016","journal-title":"Eur. J. Immunol"},{"key":"2023072812282831000_bib39","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1016\/j.celrep.2018.04.101","article-title":"Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity","volume":"23","author":"Prigent","year":"2018","journal-title":"Cell Rep"},{"key":"2023072812282831000_bib40","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1172\/JCI121957","article-title":"PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection","volume":"128","author":"Salimzadeh","year":"2018","journal-title":"J. Clin. Invest"},{"key":"2023072812282831000_bib41","doi-asserted-by":"publisher","first-page":"9321","DOI":"10.1128\/JVI.00678-09","article-title":"A function essential to viral entry underlies the hepatitis B virus \u201ca\u201d determinant","volume":"83","author":"Salisse","year":"2009","journal-title":"J. Virol"},{"key":"2023072812282831000_bib42","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1056\/NEJM199312163292503","article-title":"Liver transplantation in European patients with the hepatitis B surface antigen","volume":"329","author":"Samuel","year":"1993","journal-title":"N. Engl. J. Med"},{"key":"2023072812282831000_bib43","volume-title":"Hepadnaviruses.","author":"Seeger","year":"2013"},{"key":"2023072812282831000_bib44","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/298567a0","article-title":"Immunotherapy in nude mice of human hepatoma using monoclonal antibodies against hepatitis B virus","volume":"298","author":"Shouval","year":"1982","journal-title":"Nature."},{"key":"2023072812282831000_bib45","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1073\/pnas.79.2.650","article-title":"Selecting binding and complement-mediated lysis of human hepatoma cells (PLC\/PRF\/5) in culture by monoclonal antibodies to hepatitis B surface antigen","volume":"79","author":"Shouval","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2023072812282831000_bib46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119820","article-title":"A novel mouse model for stable engraftment of a human immune system and human hepatocytes","volume":"10","author":"Strick-Marchand","year":"2015","journal-title":"PLoS One"},{"key":"2023072812282831000_bib47","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/978-1-60761-688-7_25","article-title":"The use of hepatocytes to investigate HDV infection: the HDV\/HepaRG model","volume":"640","author":"Sureau","year":"2010","journal-title":"Methods Mol. Biol"},{"issue":"1","key":"2023072812282831000_bib48","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1016\/j.jhep.2016.02.013","article-title":"The hepatitis delta virus: Replication and pathogenesis","volume":"64","author":"Sureau","year":"2016","journal-title":"J. Hepatol"},{"key":"2023072812282831000_bib49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142145","article-title":"Generation of Novel Chimeric Mice with Humanized Livers by Using Hemizygous cDNA-uPA\/SCID Mice","volume":"10","author":"Tateno","year":"2015","journal-title":"PLoS One"},{"key":"2023072812282831000_bib50","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/jvh.12667","article-title":"Antibody-dependent and antibody-independent uptake of HBsAg across human leucocyte subsets is similar between individuals with chronic hepatitis B virus infection and healthy donors","volume":"24","author":"Tharinger","year":"2017","journal-title":"J. Viral Hepat"},{"key":"2023072812282831000_bib51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.immuni.2007.01.009","article-title":"Autoreactivity in human IgG+ memory B cells","volume":"26","author":"Tiller","year":"2007","journal-title":"Immunity"},{"key":"2023072812282831000_bib52","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"2023072812282831000_bib53","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.coviro.2018.04.004","article-title":"Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections","volume":"30","author":"Tu","year":"2018","journal-title":"Curr. Opin. Virol"},{"key":"2023072812282831000_bib54","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1034\/j.1600-0676.2001.021003207.x","article-title":"Efficacy and safety of an intravenous monoclonal anti-HBs in chronic hepatitis B patients","volume":"21","author":"van Nunen","year":"2001","journal-title":"Liver"},{"key":"2023072812282831000_bib55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/hep.28013","article-title":"A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses","volume":"63","author":"Verrier","year":"2016","journal-title":"Hepatology"},{"key":"2023072812282831000_bib56","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1126\/science.1086907","article-title":"Predominant autoantibody production by early human B cell precursors","volume":"301","author":"Wardemann","year":"2003","journal-title":"Science"},{"key":"2023072812282831000_bib57","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/0264-410X(96)00062-X","article-title":"Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination","volume":"14","author":"West","year":"1996","journal-title":"Vaccine"},{"key":"2023072812282831000_bib58","unstructured":"World Health Organization\n          . 2017. Global hepatitis report, 2017. https:\/\/www.who.int\/hepatitis\/publications\/global-hepatitis-report2017\/en\/"},{"key":"2023072812282831000_bib59","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/cmi.2015.25","article-title":"Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients","volume":"12","author":"Xu","year":"2015","journal-title":"Cell. Mol. Immunol"},{"key":"2023072812282831000_bib60","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1136\/gutjnl-2014-308964","article-title":"Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen","volume":"65","author":"Zhang","year":"2016","journal-title":"Gut"},{"key":"2023072812282831000_bib61","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.4049\/jimmunol.1502061","article-title":"Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination","volume":"196","author":"Zhu","year":"2016","journal-title":"J. Immunol"}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20200840\/1832407\/jem_20200840.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20200840\/1832407\/jem_20200840.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T08:30:25Z","timestamp":1690533025000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/217\/10\/e20200840\/151888\/Potent-human-broadly-neutralizing-antibodies-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,24]]},"references-count":61,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10,5]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20200840","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,24]]},"article-number":"e20200840"}}